ARYx Therapeutics Inc (ARYX)

Ticker: ARYX


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Growth Equity Opportunities Fund, LLC Large shareholder
Transaction date
Sale
Price
219.61
Quantity 91,074 -2.8%
Value US$3,397,540
BASKETT FOREST Large shareholder
Transaction date
Sale
Price
496.69
Quantity 19,999 +10.2%
Value US$2,332,612
KERINS PATRICK J Large shareholder
Transaction date
Sale
Price
132.87
Quantity 91,888 +27.3%
Value US$2,135,432
KOLLURI KRISHNA KITTU Large shareholder
Transaction date
Sale
Price
0.07
Quantity 4,469,274 -100.0%
Value US$326,257
DRANT RYAN D Large shareholder
Transaction date
Sale
Price
0.07
Quantity 4,469,274 -100.0%
Value US$326,257
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
4.00
Quantity 2,000,000 -59.9%
Value US$8,000,000
MPM BIOVENTURES III QP LP Large shareholder
Transaction date
Purchase
Price
2.20
Quantity 1,787,710 +50.0%
Value US$3,932,962
EVNIN LUKE Large shareholder
Transaction date
Purchase
Price
2.20
Quantity 1,787,710 +50.0%
Value US$3,932,962
SIMON NICHOLAS J III Non-Executive Director Large shareholder
Transaction date
Purchase
Price
2.20
Quantity 1,787,710 +50.0%
Value US$3,932,962
ORBIMED ADVISORS LLC Non-Executive Director
Transaction date
Purchase
Price
10.00
Quantity 300,000 +16.4%
Value US$3,000,000
Adelman Robert J Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 300,000 +inf%
Value US$3,000,000
SIMON NICHOLAS J III Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 300,000 +9.2%
Value US$3,000,000
EVNIN LUKE Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 300,000 +9.2%
Value US$3,000,000
MPM BIOVENTURES III QP LP Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 300,000 +9.2%
Value US$3,000,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2011-03-14 2011-03-10 S Sale Growth Equity Opportunities Fund, LLC Large shareholder
91,074 -2.8%
219.61
US$3,397,540
91,074 -2.8% 219.61 US$3,397,540
2011-03-14 2011-03-10 S Sale BASKETT FOREST Large shareholder
19,999 +10.2%
496.69
US$2,332,612
19,999 +10.2% 496.69 US$2,332,612
2011-03-14 2011-03-10 S Sale KERINS PATRICK J Large shareholder
91,888 +27.3%
132.87
US$2,135,432
91,888 +27.3% 132.87 US$2,135,432
2011-03-14 2011-03-10 S Sale KOLLURI KRISHNA KITTU Large shareholder
4,469,274 -100.0%
0.07
US$326,257
4,469,274 -100.0% 0.07 US$326,257
2011-03-14 2011-03-10 S Sale DRANT RYAN D Large shareholder
4,469,274 -100.0%
0.07
US$326,257
4,469,274 -100.0% 0.07 US$326,257
2009-05-26 2009-05-22 S Sale ORBIMED ADVISORS LLC Large shareholder
2,000,000 -59.9%
4.00
US$8,000,000
2,000,000 -59.9% 4.00 US$8,000,000
2008-11-17 2008-11-14 B Purchase MPM BIOVENTURES III QP LP Large shareholder
1,787,710 +50.0%
2.20
US$3,932,962
1,787,710 +50.0% 2.20 US$3,932,962
2008-11-17 2008-11-14 B Purchase EVNIN LUKE Large shareholder
1,787,710 +50.0%
2.20
US$3,932,962
1,787,710 +50.0% 2.20 US$3,932,962
2008-11-17 2008-11-14 B Purchase SIMON NICHOLAS J III Non-Executive Director Large shareholder
1,787,710 +50.0%
2.20
US$3,932,962
1,787,710 +50.0% 2.20 US$3,932,962
2007-11-15 2007-11-13 B Purchase ORBIMED ADVISORS LLC Non-Executive Director
300,000 +16.4%
10.00
US$3,000,000
300,000 +16.4% 10.00 US$3,000,000
2007-11-14 2007-11-13 B Purchase Adelman Robert J Non-Executive Director Large shareholder
300,000 +inf%
10.00
US$3,000,000
300,000 +inf% 10.00 US$3,000,000
2007-11-13 2007-11-13 B Purchase SIMON NICHOLAS J III Non-Executive Director Large shareholder
300,000 +9.2%
10.00
US$3,000,000
300,000 +9.2% 10.00 US$3,000,000
2007-11-13 2007-11-13 B Purchase EVNIN LUKE Large shareholder
300,000 +9.2%
10.00
US$3,000,000
300,000 +9.2% 10.00 US$3,000,000
2007-11-13 2007-11-13 B Purchase MPM BIOVENTURES III QP LP Large shareholder
300,000 +9.2%
10.00
US$3,000,000
300,000 +9.2% 10.00 US$3,000,000
Explore more

More insider trading research around ARYx Therapeutics Inc